Clinical Trials Browser

Phase 2 × ARX788 × CNS × Clear all

NCT05018702 2022-06-01

ARX788 in HER2-positive Breast Cancer Patients With Brain Metastases

Phase 2 Unknown

Brain Neoplasms, Breast Neoplasms